- Changes in metformin use and other antihyperglycemic therapies after insulin initiation in patients with type 2 diabetes
- Efficacy and safety of low-dose amiodarone therapy for tachyarrhythmia in congenital heart disease
- Effects of combined oral contraception containing drospirenone on premenstrual exacerbation of Meniere's disease: Preliminary study
- Intramuscular oxytocin administration before vs after placental delivery for the prevention of postpartum hemorrhage: A randomized controlled prospective trial
- A randomized, open label trial of methadone continuation vs forced withdrawal in a combined US prison and jail: Findings at 12 months post-release
- Efficacy and safety of concurrent immunoradiotherapy in patients with metastatic melanoma after progression on nivolumab
- Acetazolamide reduces retinal inner nuclear layer thickness in microcystic macular edema secondary to optic neuropathy
- Time course of reversal of valproate-mediated inhibition of lamotrigine
- Association of immune-related adverse events with nivolumab efficacy in non–small-cell lung cancer
- Pacritinib vs best available therapy, including ruxolitinib, in patients with myelofibrosis: A randomized clinical trial
- Clinical and biomarker evaluations of sunitinib in patients with grade 3 digestive neuroendocrine neoplasms
- Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: A meta-analysis of randomised controlled trials
- Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer
- Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early vs delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: The TEMPO 4:4 Trial
- The safety of iloprost in systemic sclerosis in a real-life experience
Feed Sources
